ResultsBusiness Standard
Natco Pharma Q2 profit drops 60.8% to ₹202.6 cr
GreyOak summary
Natco Pharma reported a 60.8% decline in consolidated net profit to ₹202.6 crore for the September quarter of FY27. Revenue from operations fell to ₹967.3 crore from ₹1,363 crore a year ago, while total expenses decreased to ₹776.2 crore. The company approved an interim dividend of ₹1.25 per share, and its stock price dipped 0.22% on the BSE.
What it affects
- Natco PharmaNATCOPHARMNegative -93
Net profit fell 60.8% to ₹202.6 crore.Rolling sentiment Negative -79
Source
Read the original at Business StandardMore Natco Pharma news
- NATCO Pharma Q2 profit falls 61% to Rs 203 croreBusiness Today · Results ·
- Natco Pharma Q2 profit, revenue fall; dividend declaredCNBC-TV18 · Results ·
- Natco Pharma Q2 Profit Falls 61% to Rs 203 CrNDTV Profit · Results ·